Antifungal Activities of Two New Azasordarins, GW471552 and GW471558, in Experimental Models of Oral and Vulvovaginal Candidiasis in Immunosuppressed Rats

Antonio Martı́nez(Hospital Universitario de Móstoles), Domingo Gargallo‐Viola(GlaxoSmithKline (United Kingdom)), Elena Jiménez(GlaxoSmithKline (Spain)), Santiago Ferrer(GlaxoSmithKline (Spain)), Javier Regadera(Universidad Autónoma de Madrid), John Sparrowe(GlaxoSmithKline (India)), Federico G. De las Heras(GlaxoSmithKline (Spain)), Inmaculada Santos-Álvarez(Universidad Autónoma de Madrid)
Antimicrobial Agents and Chemotherapy
December 1, 2001
Cited by 28


Related Papers